Retatrutide calculator

How often will you inject?
Is it mixed?
Which syringe will you use?
Size

The biggest number printed on the barrel.

Divide the mg in the vial by the mL of water to get the strength, then divide the dose by the strength and multiply by 100 for units. Example: 10 mg of retatrutide with 2 mL of water is 5 mg/mL, so 2 mg is 0.4 mL, or 40 units on a U-100 syringe.

Every step is shown

Open "Show the maths" and you can check each line yourself, or show it to someone you trust.

We catch the common slips

Mixing up mg and mcg, or picking the wrong syringe, are the usual mistakes. We flag both before you draw.

Your numbers stay yours

No account, no sign-up. The maths runs in your browser, and we never ask your name.

Is retatrutide FDA approved?

Not approved As of 2026-10-07, retatrutide is not approved by the FDA for any use. It is an investigational medicine made by Eli Lilly and is in phase 3 trials (the TRIUMPH programme, for example NCT05929066). Lilly has also registered a pre-approval expanded access programme (NCT07629401).

Retatrutide sold outside a trial or Lilly's programme is not an approved product. Its strength and purity can't be checked from the label, which is one more reason to check your maths twice.

Doses studied in trials

In the published phase 2 trial, adults with obesity took retatrutide once a week for 48 weeks at one of these doses. Several groups started lower and stepped up. This is what was studied, not a recommendation.

Trial groupWeekly dose
Low1 mg
Middle4 mg (two groups: started at 2 mg, or at 4 mg)
Higher8 mg (two groups: started at 2 mg, or at 4 mg)
Highest12 mg (started at 2 mg)

How much water for a 10 mg vial?

Any amount works as long as you use the same number when you calculate. Here's what 2 mg looks like on a 1 mL syringe for common choices:

2 mg on a 1 mL U-100 syringe
VialWaterStrength2 mg isDoses per vial
10 mg1 mL10 mg/mL20 units (0.2 mL)5
10 mg2 mL5 mg/mL40 units (0.4 mL)5
10 mg3 mL3.33 mg/mL60 units (0.6 mL)5

Not mixed yet? The reconstitution calculator shows which water amounts land on a line.

Sources

  1. Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. N Engl J Med 2023;389:514-526: nejm.org
  2. TRIUMPH-1 phase 3 trial record: clinicaltrials.gov
  3. Pre-approval expanded access of retatrutide: clinicaltrials.gov

Last checked 2026-10-07.

Other calculators